# Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

> **NCT02647866** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin, Inc.** · enrollment: 66 (actual)

## Conditions studied

- Ulcerative Colitis
- Digestive System Diseases
- Colitis, Ulcerative
- Colitis
- Gastrointestinal Diseases
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Colonic Diseases
- Autoimmune Disease
- Abdominal Pain

## Interventions

- **DRUG:** KHK4083
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02647866
- **Lead sponsor:** Kyowa Kirin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-09
- **Final completion:** 2018-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02647866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02647866, "Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02647866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*